Sangamo Therapeutics, Inc.
Nuclease-mediated regulation of gene expression
Last updated:
Abstract:
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
Status:
Grant
Type:
Utility
Filling date:
12 May 2016
Issue date:
20 Oct 2020